AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45
IFN-BETA PARTIALLY COUNTERACTS INHIBITION OF NATURAL-KILLER ACTIVITY-INDUCED BY SOME ANTITUMOR AGENTS
Authors: ALLAVENA P GIARDINA G SEN S COLELLA G BROGGINI M DINCALCI M
Citation: P. Allavena et al., IFN-BETA PARTIALLY COUNTERACTS INHIBITION OF NATURAL-KILLER ACTIVITY-INDUCED BY SOME ANTITUMOR AGENTS, Journal of interferon & cytokine research, 18(2), 1998, pp. 87-93
MOLECULAR CHARACTERIZATION OF A PANEL OF HUMAN OVARIAN-CARCINOMA XENOGRAFTS
Authors: CODEGONI AM NICOLETTI MI BURAGGI G VALOTI G GIAVAZZI R DINCALCI M LANDONI F MANEO A BROGGINI M
Citation: Am. Codegoni et al., MOLECULAR CHARACTERIZATION OF A PANEL OF HUMAN OVARIAN-CARCINOMA XENOGRAFTS, European journal of cancer, 34(9), 1998, pp. 1432-1438
DNA-TOPOISOMERASE-I ACTIVITY AND CONTENT IN EPITHELIAL OVARIAN-CANCER
Authors: CODEGONI AM CASTAGNA S MANGIONI C SCOVASSI AI BROGGINI M DINCALCI M
Citation: Am. Codegoni et al., DNA-TOPOISOMERASE-I ACTIVITY AND CONTENT IN EPITHELIAL OVARIAN-CANCER, Annals of oncology, 9(3), 1998, pp. 313-319
PNU-151807 (ALPHA-BROMOACRYLOYL DISTAMYCIN-A) - A NEW NONCOVALENT MINOR-GROOVE DNA BINDER WITH ANTINEOPLASTIC ACTIVITY
Authors: MARCHINI S CIRO M GERONI C COZZI P BROGGINI M
Citation: S. Marchini et al., PNU-151807 (ALPHA-BROMOACRYLOYL DISTAMYCIN-A) - A NEW NONCOVALENT MINOR-GROOVE DNA BINDER WITH ANTINEOPLASTIC ACTIVITY, Annals of oncology, 9, 1998, pp. 529-529
SEQUENCE-SPECIFIC DNA ALKYLATION OF NOVEL TALLIMUSTINE DERIVATIVES
Authors: MARCHINI S COZZI P BERIA I GERONI C CAPOLONGO L DINCALCI M BROGGINI M
Citation: S. Marchini et al., SEQUENCE-SPECIFIC DNA ALKYLATION OF NOVEL TALLIMUSTINE DERIVATIVES, Anti-cancer drug design, 13(3), 1998, pp. 193-205
HMLH1 AND HMSH2 EXPRESSION AND BAX FRAMESHIFT MUTATIONS IN OVARIAN-CANCER CELL-LINES AND TUMORS
Authors: COLELLA G VIKHANSKAYA F CODEGONI AM BONAZZI C DINCALCI M BROGGINI M
Citation: G. Colella et al., HMLH1 AND HMSH2 EXPRESSION AND BAX FRAMESHIFT MUTATIONS IN OVARIAN-CANCER CELL-LINES AND TUMORS, Carcinogenesis, 19(4), 1998, pp. 691-694
INACTIVATION OF P53 IN A HUMAN OVARIAN-CANCER CELL-LINE INCREASES THESENSITIVITY TO PACLITAXEL BY INDUCING G2 M ARREST AND APOPTOSIS/
Authors: VIKHANSKAYA F VIGNATI S BECCAGLIA P OTTOBONI C RUSSO P DINCALCI M BROGGINI M
Citation: F. Vikhanskaya et al., INACTIVATION OF P53 IN A HUMAN OVARIAN-CANCER CELL-LINE INCREASES THESENSITIVITY TO PACLITAXEL BY INDUCING G2 M ARREST AND APOPTOSIS/, Experimental cell research, 241(1), 1998, pp. 96-101
EFFECT OF G-C-]A-T TRANSITION, POTENTIALLY ARISING FROM O-6-GUANINE ALKYLATION, IN THE TRANSCRIPTION REGULATION OF C-FOS SERUM RESPONSE ELEMENT
Authors: BONFANTI M COLELLA G BROGGINI M DINCALCI M
Citation: M. Bonfanti et al., EFFECT OF G-C-]A-T TRANSITION, POTENTIALLY ARISING FROM O-6-GUANINE ALKYLATION, IN THE TRANSCRIPTION REGULATION OF C-FOS SERUM RESPONSE ELEMENT, Anticancer research, 17(3C), 1997, pp. 2019-2024
P21 PEPTIDES LINKED TO AN INTERNALIZATION PEPTIDE EXHIBIT HIGH GROWTH-INHIBITION OF HUMAN CANCER-CELLS
Authors: BONFANTI M TAVERNA S SALMONA M DINCALCI M BROGGINI M
Citation: M. Bonfanti et al., P21 PEPTIDES LINKED TO AN INTERNALIZATION PEPTIDE EXHIBIT HIGH GROWTH-INHIBITION OF HUMAN CANCER-CELLS, European journal of cell biology, 72, 1997, pp. 39-39
EXPRESSION OF GENES OF POTENTIAL IMPORTANCE IN THE RESPONSE TO CHEMOTHERAPY AND DNA-REPAIR IN PATIENTS WITH OVARIAN-CANCER
Authors: CODEGONI AM BROGGINI M PITELLI MR PANTAROTTO M TORRI V MANGIONI C DINCALCI M
Citation: Am. Codegoni et al., EXPRESSION OF GENES OF POTENTIAL IMPORTANCE IN THE RESPONSE TO CHEMOTHERAPY AND DNA-REPAIR IN PATIENTS WITH OVARIAN-CANCER, Gynecologic oncology, 65(1), 1997, pp. 130-137
MECHANISM OF RESISTANCE TO CISPLATIN IN A HUMAN OVARIAN-CARCINOMA CELL-LINE SELECTED FOR RESISTANCE TO DOXORUBICIN - POSSIBLE ROLE OF P53
Authors: VIKHANSKAYA F CLERICO L VALENTI M STANZIONE MS BROGGINI M PARODI S RUSSO P
Citation: F. Vikhanskaya et al., MECHANISM OF RESISTANCE TO CISPLATIN IN A HUMAN OVARIAN-CARCINOMA CELL-LINE SELECTED FOR RESISTANCE TO DOXORUBICIN - POSSIBLE ROLE OF P53, International journal of cancer, 72(1), 1997, pp. 155-159
P21(WAF1)-DERIVED PEPTIDES LINKED TO AN INTERNALIZATION PEPTIDE INHIBIT HUMAN CANCER CELL-GROWTH
Authors: BONFANTI M TAVERNA S SALMONA M DINCALCI M BROGGINI M
Citation: M. Bonfanti et al., P21(WAF1)-DERIVED PEPTIDES LINKED TO AN INTERNALIZATION PEPTIDE INHIBIT HUMAN CANCER CELL-GROWTH, Cancer research, 57(8), 1997, pp. 1442-1446
P53 STATUS DOES NOT AFFECT SENSITIVITY OF HUMAN OVARIAN-CANCER CELL-LINES TO PACLITAXEL
Authors: DEBERNARDIS D SIRE EG DEFEUDIS P VIKHANSKAYA F VALENTI M RUSSO P PARODI S DINCALCI M BROGGINI M
Citation: D. Debernardis et al., P53 STATUS DOES NOT AFFECT SENSITIVITY OF HUMAN OVARIAN-CANCER CELL-LINES TO PACLITAXEL, Cancer research, 57(5), 1997, pp. 870-874
DDP-INDUCED CYTOTOXICITY IS NOT INFLUENCED BY P53 IN 9 HUMAN OVARIAN-CANCER CELL-LINES WITH DIFFERENT P53 STATUS
Authors: DEFEUDIS P DEBERNARDIS D BECCAGLIA P VALENTI M SIRE EG ARZANI D STANZIONE S PARODI S DINCALCI M RUSSO P BROGGINI M
Citation: P. Defeudis et al., DDP-INDUCED CYTOTOXICITY IS NOT INFLUENCED BY P53 IN 9 HUMAN OVARIAN-CANCER CELL-LINES WITH DIFFERENT P53 STATUS, British Journal of Cancer, 76(4), 1997, pp. 474-479
ABSENCE OF DELETIONS BUT FREQUENT LOSS OF EXPRESSION OF P16(INK4) IN HUMAN OVARIAN-TUMORS
Authors: MARCHINI S CODEGONI AM BONAZZI C CHIARI S BROGGINI M
Citation: S. Marchini et al., ABSENCE OF DELETIONS BUT FREQUENT LOSS OF EXPRESSION OF P16(INK4) IN HUMAN OVARIAN-TUMORS, British Journal of Cancer, 76(2), 1997, pp. 146-149
BONE MINERALIZATION AND BODY-COMPOSITION IN YOUNG-PATIENTS WITH CELIAC-DISEASE
Authors: SCOTTA MS SALVATORE S SALVATONI A DEAMICI M GHIRINGHELLI D BROGGINI M NESPOLI L
Citation: Ms. Scotta et al., BONE MINERALIZATION AND BODY-COMPOSITION IN YOUNG-PATIENTS WITH CELIAC-DISEASE, The American journal of gastroenterology, 92(8), 1997, pp. 1331-1334
COMPUTED RADIOGRAPHIC ABSORPTIOMETRY AND MORPHOMETRY IN THE ASSESSMENT OF POSTMENOPAUSAL BONE LOSS
Authors: ADAMI S ZAMBERLAN N GATTI D ZANFISI C BRAGA V BROGGINI M ROSSINI M
Citation: S. Adami et al., COMPUTED RADIOGRAPHIC ABSORPTIOMETRY AND MORPHOMETRY IN THE ASSESSMENT OF POSTMENOPAUSAL BONE LOSS, Osteoporosis international, 6(1), 1996, pp. 8-13
CANCER AND THE CELL-CYCLE - LAUSANNE, SWITZERLAND, JANUARY 17-20, 1996
Authors: BROGGINI M
Citation: M. Broggini, CANCER AND THE CELL-CYCLE - LAUSANNE, SWITZERLAND, JANUARY 17-20, 1996, Annals of oncology, 7(4), 1996, pp. 343-345
P53 REGULATES THE MINIMAL PROMOTER OF THE HUMAN TOPOISOMERASE II-ALPHA GENE
Authors: SANDRI MI ISAACS RJ ONGKEKO WM HARRIS AL HICKSON ID BROGGINI M VIKHANSKAYA F
Citation: Mi. Sandri et al., P53 REGULATES THE MINIMAL PROMOTER OF THE HUMAN TOPOISOMERASE II-ALPHA GENE, Nucleic acids research, 24(22), 1996, pp. 4464-4470
CHARACTERIZATION OF A PROTEIN RECOGNIZING MINOR-GROOVE BINDERS-DAMAGED DNA
Authors: COLELLA G BONFANTI M DINCALCI M BROGGINI M
Citation: G. Colella et al., CHARACTERIZATION OF A PROTEIN RECOGNIZING MINOR-GROOVE BINDERS-DAMAGED DNA, Nucleic acids research, 24(21), 1996, pp. 4227-4233
CHANGES IN CYCLINS AND CYCLIN-DEPENDENT KINASES INDUCED BY DNA-DAMAGING AGENTS IN A HUMAN OVARIAN-CANCER CELL-LINE EXPRESSING MUTATED OR WILD-TYPE P53
Authors: VIKHANSKAYA F ERBA E DINCALCI M BROGGINI M
Citation: F. Vikhanskaya et al., CHANGES IN CYCLINS AND CYCLIN-DEPENDENT KINASES INDUCED BY DNA-DAMAGING AGENTS IN A HUMAN OVARIAN-CANCER CELL-LINE EXPRESSING MUTATED OR WILD-TYPE P53, Experimental cell research, 227(2), 1996, pp. 380-385
EFFECTS OF ORAL ALENDRONATE AND INTRANASAL SALMON-CALCITONIN ON BONE MASS AND BIOCHEMICAL MARKERS OF BONE TURNOVER IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
Authors: ADAMI S PASSERI M ORTOLANI S BROGGINI M CARRATELLI L CARUSO I GANDOLINI G GNESSI L LAURENZI M LOMBARDI A NORBIATO G PRYORTILLOTSON S REDA C ROMANINI L SUBRIZI D WEI L YATES AJ
Citation: S. Adami et al., EFFECTS OF ORAL ALENDRONATE AND INTRANASAL SALMON-CALCITONIN ON BONE MASS AND BIOCHEMICAL MARKERS OF BONE TURNOVER IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS, Bone, 17(4), 1995, pp. 383-390
SERUM LEVELS OF GAMMA-INTERFERON, NEOPTERIN AND INTERLEUKIN-10 IN PATIENTS WITH DOWNS-SYNDROME
Authors: TORRE D BROGGINI M ZEROLI C GIOLA M DEFRANCESCO D AGRIFOGLIO L BOTTA V FERRARIO G
Citation: D. Torre et al., SERUM LEVELS OF GAMMA-INTERFERON, NEOPTERIN AND INTERLEUKIN-10 IN PATIENTS WITH DOWNS-SYNDROME, FCI. Fundamental and clinical immunology, 3(1), 1995, pp. 29-32
SENSITIVITY AND CELLULAR-RESPONSE TO DIFFERENT ANTICANCER AGENTS OF AHUMAN OVARIAN-CANCER CELL-LINE EXPRESSING WILD-TYPE, MUTATED OR NO P53
Authors: SIRE EAG VIKHANSKAYA F BROGGINI M
Citation: Eag. Sire et al., SENSITIVITY AND CELLULAR-RESPONSE TO DIFFERENT ANTICANCER AGENTS OF AHUMAN OVARIAN-CANCER CELL-LINE EXPRESSING WILD-TYPE, MUTATED OR NO P53, Annals of oncology, 6(6), 1995, pp. 589-593
DNA SEQUENCE-SPECIFIC ADENINE ALKYLATION BY THE NOVEL ANTITUMOR DRUG TALLIMUSTINE (FCE-24517), A BENZOYL NITROGEN-MUSTARD DERIVATIVE OF DISTAMYCIN
Authors: BROGGINI M COLEY HM MONGELLI N PESENTI E WYATT MD HARTLEY JA DINCALCI M
Citation: M. Broggini et al., DNA SEQUENCE-SPECIFIC ADENINE ALKYLATION BY THE NOVEL ANTITUMOR DRUG TALLIMUSTINE (FCE-24517), A BENZOYL NITROGEN-MUSTARD DERIVATIVE OF DISTAMYCIN, Nucleic acids research, 23(1), 1995, pp. 81-87
Risultati: 1-25 | 26-45